Lincoln Pharmaceuticals informs about board meeting

Lincoln Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter and Half year ended 30.09.2026.

The above information is a part of company’s filings submitted to BSE.